A randomized, double-blind, multicenter phase III study evaluating paclitaxel with and without RAD001 in patients with gastric cancer who have progressed after therapy

被引：32

作者：

Al-Batran, Salah-Eddin

Riera-Knorrenschild, Jorge

Pauligk, Claudia

Goetze, Thorsten Oliver

Hegewisch-Becker, Susanna

Seraphin, Jorg

Thuss-Patience, Peter C.

Kopp, Hans-Georg

Dechow, Tobias Nicolaas

Vogel, Arndt

Luley, Kim Barbara

Pink, Daniel

Stahl, Michael

Kullmann, Frank

Hebart, Holger Frithjof

Siveke, Jens T.

Egger, Matthias

Homann, Nils

Probst, Stephan

Lorenzen, Sylvie

机构：

[1] Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany

[2] Univ Klinikum Giessen & Marburg, Marburg, Germany

[3] HOPE Hamatol Onkol Praxis Eppendorf, Hamburg, Germany

[4] Helios MVZ Sudniedersachsen GmbH, Northeim, Germany

[5] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[6] Univ Hosp, Med Ctr 2, Tubingen, Germany

[7] Onkol Ravensburg, Ravensburg, Germany

[8] Hannover Med Sch, Hannover, Germany

[9] UKSH Campus Luebeck, Lubeck, Germany

[10] Helios Klinikum Bad Saarow, Bad Saarow Pieskow, Germany

[11] Kliniken Essen Mitte, Dept Med Oncol, Essen, Germany

[12] Nordoberpfalz Hosp, Dept Med 1, Weiden, Germany

[13] Staufer Klinikum, Mutlangen, Germany

[14] Tech Univ, Dept Internal Med 2, Munich, Germany

[15] Lahr Med Clin, Ortenau Clin, Lahr, Germany

[16] Acad Teaching Hosp Wolfsburg, Dept Internal Med 2, Wolfsburg, Germany

[17] Klinikum Bielefeld, Bielefeld, Germany

[18] Tech Univ Munich, Dept Internal Med Hematol Med Oncol 3, Klinikum Rechts Isar, Munich, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期

关键词：

D O I：

10.1200/JCO.2017.35.4_suppl.4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2